AMRS News 3.89 08/14/2014 04:33:16 Amyris Inc (AMRS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amyris Inc (AMRS) 3.89 $AMRS

Amyris Reports Second Quarter 2014 Financial Results
GlobeNewswire - Thu Aug 07, 3:44PM CDT
-- End of quarter cash, cash equivalents and short-term investments balance of $90.2 million.

First International Commercial Flight Completed With Newly Approved Amyris-Total Aviation Biofuel
GlobeNewswire - Thu Jul 31, 12:52PM CDT
Yesterday, Amyris (Nasdaq:AMRS), an industrial bioscience company, partnered with Brazilian airline, GOL, to fly the industry's first commercial flight with farnesane, the recently approved renewable jet fuel. The first flight, GOL flight 7725, departed from Orlando, Florida on July 30, 2014 at 5:15 PM ET and traveled to Sao Paulo, Brazil.

Global Synthetic Biology Market 2014-2018
M2 - Mon Jul 28, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4xp9d8/global_synthetic) has announced the addition of the "Global Synthetic Biology Market 2014-2018" report to their offering. The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment. The analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018. The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Technology 08. Market Segmentation by Product 09. Market Segmentation by Applications 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - Amyris Inc. - E. I. du Pont de Nemours and Co. - Thermo Fisher Scientific Inc. - Synthetic Genomics Inc. - Algenol Biofuels Inc. - ATG:biosynthetics GmbH - Bayer AG - Bioneer Corp. - Biosearch Technologies Inc. - Bristol-Myers Squibb Co. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - Evolva Holdings SA - Exxon Mobil Corp. - GeneWorks Pty Ltd. - Genomatica Inc. - Gevo Inc. - Ginkgo Bioworks - Green Biologics Ltd. - New England Biolabs Inc. - OriGene Technologies Inc. - REG Life Sciences LLC - Royal DSM - Synthorx Inc. For more information visit http://www.researchandmarkets.com/research/4x..._synthetic

Commit To Purchase Amyris At $2.50, Earn 15.3% Annualized Using Options
StockOptionsChannel.com - Fri Jul 25, 10:29AM CDT
Investors eyeing a purchase of Amyris, Inc. shares, but cautious about paying the going market price of $3.63/share, might benefit from considering selling puts among the alternative strategies at their disposal.

4 Cash-Strapped Companies on Life Support - Investment Ideas
Todd Bunton - ZACKS - Thu Jul 24, 5:15PM CDT
4 Cash-Strapped Companies on Life Support - Investment Ideas

Amyris to Announce Second Quarter Financial Results on Thursday, August 7, 2014
GlobeNewswire - Thu Jul 17, 7:17AM CDT
Amyris, Inc. (Nasdaq:AMRS) will report financial results for the second quarter ended June 30, 2014 after market close on Thursday, August 7, 2014.

Brazilian Airline GOL to Make First International Commercial Flights With Newly Approved Amyris-Total Aviation Biofuel
GlobeNewswire - Wed Jul 09, 7:00AM CDT
Amyris (Nasdaq:AMRS) has partnered with Brazilian airline GOL (NYSE:GOL) to begin the first commercial route with farnesane, the recently approved renewable jet fuel.

Should Amyris Investors Fear Intrexon's Farnesene?
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Jul 07, 1:09PM CDT
When a company commercializes a building-block molecule with dozens, if not hundreds, of potential commercial uses, competition is bound to arrive sooner or later. When it comes to farnesene production, that competition may show up sooner than ...

What's the Value of Amyris' Molecule Development Strategy?
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Jun 18, 11:50AM CDT
Artemisinin-based combination therapies are some of the most important weapons wielded by the developing world against malaria, which claims over 620,000 lives each year. While artemisinin is effective, its supply and cost is greatly affected by...

2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019
M2 - Wed Jun 18, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9bcz55/synthetic_biology) has announced the addition of the "2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019" report to their offering. Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. While enabling products are segmented into DNA and oligonucleotide synthesis products. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Synthetic Biology Market, by Products Chapter 5 Global Synthetic Biology Market, by Technologies Chapter 6 Global Synthetic Biology Market, by Applications Chapter 7 Global Synthetic Biology Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned: - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/9b...ic_biology

Amyris Up 5.2%, Shares Break Through Resistance (AMRS)
Comtex SmarTrend(R) - Tue Jun 17, 11:39AM CDT
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 5.2% to $3.85 on 1.2x average daily volume. Thus far today, Amyris has traded 326,000 shares, vs. average volume of 269,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's 0.1%) and outperformed the S&P 500 (5.2% to the S&P's 0.1%) during today's trading.

Total and Amyris Renewable Jet Fuel Ready for Use in Commercial Aviation
GlobeNewswire - Mon Jun 16, 6:55AM CDT
With the newly revised ASTM standard for jet fuel, Amyris (Nasdaq:AMRS) and Total (CAC:TOTF.PA) today begin to prepare to market a drop-in jet fuel that contains up to 10% blends of renewable farnesane.

A Warning for Biofuel Investors
Shamus Funk, The Motley Fool - Motley Fool - Thu Jun 12, 9:57AM CDT
It's hard to believe a company producing and selling shark liver oil and low-friction tire rubber could be telling a story that we've already heard before, but Amyris ' tale is one not unseen in the bio-product industry. Like a poorly written...

Takasago and Amyris to Begin Commercialization of Novel Fragrance Products
GlobeNewswire - Mon Jun 09, 6:12AM CDT
Takasago (TYO:4914), a global leader in the creation of flavors and fragrances for consumer products, and Amyris (Nasdaq:AMRS), a leading renewable products company, today announced the start of the next phase of their relationship to commercialize farnesene-derived fragrance molecules. Having successfully completed feasibility testing, Takasago agreed to move forward with commercialization, starting with a first purchase for scale-up this quarter.

4 Stocks Under $10 Making Big Moves
at The Street - Wed Apr 02, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Why Amyris (AMRS) Shares Are Jumping Today
at The Street - Tue Apr 01, 3:00PM CDT
Shares of Amyris (AMRS) are jumping Tuesday following a report from the United States Maritime Administration that compared an Amyris Renewable Diesel Fuel mixture to regular ultralow sulfur diesel fuel, and found reduced air emission with not...

Amyris extends partnership with Kuraray for farnesene-based polymers
M2 - Mon Mar 31, 7:38AM CDT
Renewable products company Amyris (NasdaqGS:AMRS) said on Monday that it has extended its ongoing collaboration in high performance polymers using its brand of renewable farnesene.

Amyris and Kuraray Expand Collaboration in Farnesene-Based Polymers
GlobeNewswire - Mon Mar 31, 7:15AM CDT
Amyris, Inc. (Nasdaq:AMRS), the leading synthetic biology innovator and renewable products company, and Kuraray Co., Ltd. (TSE:3405), a pioneering global chemical products company with a long history of commercializing a range of resins, fibers, textiles and other materials, announced today the expansion and extension of their ongoing collaboration in high performance polymers using Biofene(R), Amyris's brand of renewable farnesene.

Clean Energy Investment Is Falling, but That's Good News -- for Solar Stocks
Alex Planes, The Motley Fool - Motley Fool - Sun Mar 23, 2:15PM CDT
Clean energy was one of the hottest investments on the market last year. Once-moribund solar stocks shone brightly, wind energy whipped stagnant share prices into a roaring gale of gains, and even formerly abandoned biofuel hopefuls began to look...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vail’s Board Fight Puts Strategy Under a Sharp Lens

Updated Category News Views 105

Fresh snow does not make a boardroom dispute disappear. Vail Resorts has put out an investor presentation ahead of its December 14, 2026 annual meeting, asking shareholders to support all nine of management’s director nominees on its white proxy card. That is the formal message. The real message is plainer: NYSE:MTN knows this election has become a test of whether...

Continue Reading
Neusoft's OneCoreGo Win Puts Auto Software in Focus

Updated Category News Views 65

A Dashboard Award Is Not Just About Pretty Pixels Crystal-like graphics and augmented-reality pathways may sound like the sort of thing a marketing department dreams up after too much coffee, but the more interesting bit in Neusoft's latest news is the machinery underneath. OneCoreGo 7.0 has received the Red Dot Design Award after taking a German iF Design Award earlier...

Continue Reading
IQSTEL’s 2027 Plan Has Scale but Still Needs Proof

Updated Category News Views 46

A $313 million nine-month revenue figure gets attention, yet this story is really about whether IQSTEL can finally turn a big telecom pipe into money that sticks. The company grew consolidated revenue 34.5% year over year through September 30, 2026, and third-quarter revenue hit $106.0 million, its second straight quarter above $100 million. That is real operating scale,...

Continue Reading
TSA at 25: Security Mission Meets a Tough Travel Reality

Updated Category News Views 104

Twenty-five years after its birth from catastrophe, TSA is still carrying a job nobody should take lightly. The agency marked its anniversary on November 19, 2026, looking back to the September 11, 2001 attacks that led to federalized aviation screening and a permanent reshaping of how Americans move through airports. This is not the sort of milestone that deserves...

Continue Reading
Winter Leaks Can Lock In Tarrant Sewer Costs for 2027

Updated Category News Views 44

Silent toilet seepage has a nasty habit of turning winter into a twelve-month utility hangover. Tarrant County homeowners are heading into the period when some local cities use household water consumption to calculate residential sewer charges for the following year. That is not the sort of detail anybody enjoys thinking about during the holidays, but ignoring it can be...

Continue Reading
Highway 99 Truck Death Puts Safety Records in Focus

Updated Category News Views 97

A stopped car on a highway shoulder is supposed to be a bad day, not a death sentence. Yet on November 5, 2026, a person helping a relative with a disabled vehicle was killed on northbound Highway 99 in Elk Grove after a commercial tractor-trailer allegedly drifted onto the shoulder, hit both stationary vehicles, and overturned. Northbound lanes were closed for hours. A...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 109

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 102

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 146

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading
Pickleman’s Chips Turn a Side Into a Brand Signal Now

Updated Category News Views 79

A bag of dill pickle chips is hardly earthshaking news, yet this one says plenty about where fast-casual brands are trying to compete. Pickleman’s Gourmet Cafe is launching its own proprietary chip line with non-GMO ingredients, sunflower oil, a pared-down ingredient profile, and a flavor that actually fits the name on the door. More importantly, a portion of each...

Continue Reading

Top 5 Most Recently Viewed Articles

FRNT Financial Expands Its Investment Portfolio with BTC

Updated Category News Views 101

FRNT Financial's New Bitcoin Acquisition FRNT Financial Inc. has made headlines with the recent purchase of 3.14 BTC (Bitcoin), which totals an impressive C$500,000, roughly equivalent to US$115,594 per BTC. This acquisition highlights the company’s robust strategy to widen its investment horizons by venturing into digital assets, showcasing their keen understanding of...

Continue Reading
Pasinex Reports Q2 2025 Results with Key Developments Ahead

Updated Category News Views 143

Pasinex Resources Limited Financial Highlights Pasinex Resources Limited (CSE: PSE) has released its financial results for the second quarter ended June 30, 2025. The company’s latest earnings report highlights both challenges and strategic advancements as it aims for growth in the zinc market. Quarterly Performance Overview In Q2 2025, Pasinex reported a net loss of...

Continue Reading
Join the Class Action Against Perpetua Resources Corp. Today

Updated Category News Views 201

Understanding the Class Action Against Perpetua Resources Corp. In recent developments, a significant class action lawsuit has been initiated on behalf of investors in Perpetua Resources Corp. (NASDAQ: PPTA). This lawsuit arises from allegations that the company misrepresented critical information regarding the Stibnite Gold Project, leading to substantial financial...

Continue Reading
Celebrating Excellence: 2026 ACGME International Award Recipients

Updated Category News Views 304

Celebrating the 2026 ACGME International Awards In a significant announcement that highlights dedication to global medical education, ACGME International (ACGME-I) celebrates the recipients of the 2026 ACGME International Awards. These awards recognize exceptional individuals within institutions accredited by ACGME-I, shining a light on their commitment to enhancing...

Continue Reading
APTIM Achieves Top 10 Ranking in Environmental Management Again

Updated Category News Views 79

APTIM Maintains Stellar Position in Environmental Rankings In an impressive feat for the fourth consecutive year, APTIM has been celebrated in the Top 10 Environmental Management Firms according to a prestigious ranking by Engineering News-Record (ENR). This year, APTIM proudly holds the seventh position in environmental management and tenth in the nuclear waste category....

Continue Reading